Novel tissue engineering strategies based on the combination of polymeric devices and adult stem cells for cardiac repair

• Autores: Paula Díaz Herráez
• Directores de la Tesis: María José Blanco Prieto (dir. tes.), Elisa Garbayo Atienza (codir. tes.)
• Lectura: En la Universidad de Navarra ( España ) en 2015
• Idioma: español
• Tribunal Calificador de la Tesis: María del Rocío Herrero Vanrell (presid.), Aránzazu Gonzalez Miqueo (secret.), María de los Reyes Elizalde González (voc.), Pieter Jelle Dijkstra (voc.), Manuel María Mazo Vega (voc.)
• Materias:
  • Ciencias médicas
    • Farmacología
      • Evaluación de medicamentos
• Enlaces
  • Tesis en acceso abierto en: Dadun
• Resumen

  • Cardiovascular diseases (CVD) are the leading cause of death worldwide. Among them, myocardial infarction (MI) is the main CVDs, causing 7.4 million deaths each year. The current therapies for MI are palliative rather than regenerative. Since that, the tissue engineering (TE) strategy has grown investigators attention. With the aim of improving heart repair after MI, we have developed two TE strategies. The first strategy was the use of poly(lactic co-glycolic acid) (PLGA) microparticles (MPs) containing neuregulin (NRG), as support for attaching adipose-derived stem cells (ADSC): ADSC-NRG-MP. The second strategy was the combination of two different polymeric devices, MPs and hydrogels. The MPs loaded with NRG were embedded together with the ADSCs in hydrogels composed of different ratios of dextran (Dex) and hyaluronic acid (HA). Our hypothesis was that the developed systems would increase cell survival and would activate different pathways to favor heart regeneration.

    The ADSC-NRG-MP induced a more pronounced regeneration of the infarcted heart in a rat MI model (reduction in infarct size, higher left ventricle thickness and vasculogenesis). Also the employment of MPs as support for the ADSC, favored a long-term survival of the cells once in the tissue, being detectable three months after their administration. Moreover, among the hydrogels developed, the 50:50 Dex:HA hydrogel embedding 1 mg of NRG-MP and 500,000 ADSC showed to present the best characteristics (adequate stiffness for heart administration, prolonged gelation time to allow its injectability and degradation rate to allow cell survival). To conclude, the two strategies developed have shown to be promising candidates for heart repair after a MI.